CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 180 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,426,000 | -63.6% | 90,000 | -54.0% | 1.09% | -47.1% |
| Q1 2022 | $6,659,000 | -79.6% | 195,500 | -76.8% | 2.07% | -70.1% |
| Q4 2021 | $32,612,000 | -38.5% | 844,000 | -14.3% | 6.92% | -30.2% |
| Q3 2021 | $53,045,000 | +61.0% | 985,000 | 0.0% | 9.91% | +81.1% |
| Q2 2021 | $32,938,000 | +62.3% | 985,000 | 0.0% | 5.47% | +83.6% |
| Q1 2021 | $20,291,000 | +16.7% | 985,000 | -0.7% | 2.98% | +31.3% |
| Q4 2020 | $17,380,000 | +18.1% | 992,000 | 0.0% | 2.27% | -21.1% |
| Q3 2020 | $14,711,000 | +5.7% | 992,000 | -7.4% | 2.88% | +2.3% |
| Q2 2020 | $13,923,000 | – | 1,071,000 | – | 2.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |